Leukemia

Partnership enables use of Sysmex’s innovative technology with Advanced Instruments’ novel GloCyte Automated Cell Counter System

For the first time, a team of international researchers has mapped the family trees of cancer cells in acute myeloid leukaemia to understand how this blood cancer responds to a new drug, enasidenib

The findings, reported in Oncogene, mean that the drug, clofarabine (Clolar™) soon could be tested in a clinical trial for this cancer, found in bone or soft tissue

The production of healthy red blood cells is critical for those with acute myeloid leukemia but is sometimes overlooked as conventional treatments focus on killing the leukemia cells alone

Charting the genomic landscape of T-lineage acute lymphoblastic leukemia patients revealed insights that will guide research and help to lay the foundation for more targeted therapy

Researchers at the Wake Forest Institute for Regenerative Medicine and colleagues are using human stem cells to measure the effects of deep space radiation

Inhibiting the editing enzyme may provide a new therapeutic approach for blood cancers

Rich, creamy, nutritious and now cancer fighting. New research reveals that molecules derived from avocados could be effective in treating a form of cancer.

Chemoresistance or the specific resistance acquired by cells to the action of certain chemicals commonly hinders the treatment of cancer. Existing ways to address this issue revolve around using competitive inhibitors, but have limited success. Now, a research team led by Assistant Professor Edward Chow of the Cancer Science Institute of Singapore (CSI) at NUS has found that binding multiple molecules of a common leukaemia drug with nanodiamonds can neutralise chemoresistance.